partners

Automotive Media Partners, LLC – Serving Auto Industry Leaders, Car Dealers and High Quality Suppliers

New feature offered as free trial to help dealers sell vehicles during COVID-19Albany, N.Y. – May 11, 2020 – Auto/Mate, a business unit of DealerSocket, has added a remote signing feature to its eDEAL™ Signature Capture digital contracting tool. The new feature is being offered to Auto/Mate’s current eDEAL customers as a free trial, helping them to overcome adverse sales conditions and close more deals while COVID-19 shelter-in-place mandates are still enforced state by state. “We’ve recognized the importance of embracing digital retailing over the past few years,” said Mike Esposito, president of Auto/Mate. “And given the present circumstances, this type of technology has now become more important than ever. We challenged our developers to quickly step up to the plate and provide a solution to a serious problem impacting dealers, and they exceeded all expectations.” When a car buyer agrees to purchase a vehicle over the phone, the dealership
Read More

Bicycle Therapeutics partners with Roche

Bicycle Therapeutics, a Cambridge, UK-based biotech, developing proprietary bicyclic peptides has attracted the attention of Roche subsidiary, Genentech. The two companies agreed a collaboration agreement, with Bicycle receiving $30m (€27.4m) in an upfront fee and eligible for a further $1.7bn (€1.55bn) dependent upon milestones met.

The focus will be on the development of small molecules aimed at immuno-oncology (IO) targets. A spokesperson for Bicycle told us that this will allow the company to expand its footprint in the IO space.

When asked in particular what targets would be worked on, the spokesperson only confirmed that they are ‘well-known’ targets that Genentech believes are “particularly well-suited to Bicycle technology.”

Bicyclic peptides are synthetic short peptides constrained to form two loops. According to the company, they combine the pharmacology of a biologic with the pharmacokinetic properties of a small molecule.

In terms of what advantages this may confer, the spokesperson explained

Read More